Chargement en cours...

Indoleamine 2,3-dioxygenase vaccination

Indoleamine 2,3-dioxygenase (IDO) is an immunoregulatory enzyme. Remarkably, we discovered IDO-specific T cells that can influence adaptive immune reactions in patients with cancer. Further, a recent phase I clinical trial demonstrated long-lasting disease stabilization without toxicity in patients...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncoimmunology
Auteurs principaux: Andersen, Mads Hald, Svane, Inge Marie
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2015
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4368142/
https://ncbi.nlm.nih.gov/pubmed/25949864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/2162402X.2014.983770
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!